3SBio Inc. (TRSBF)
OTCMKTS · Delayed Price · Currency is USD
2.510
0.00 (0.00%)
At close: Feb 9, 2026
3SBio Market Cap
3SBio has a market cap or net worth of $7.71 billion as of February 12, 2026. Its market cap has increased by 301.83% in one year.
Market Cap
7.71B
Enterprise Value
7.43B
Revenue
1.27B
Ranking
n/a
PE Ratio
23.41
Stock Price
$2.51
Market Cap Chart
Since June 11, 2015, 3SBio's market cap has increased from 2.92B to 7.71B, an increase of 163.57%. That is a compound annual growth rate of 9.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 7.71B | -0.68% |
| Dec 31, 2025 | 7.76B | 320.88% |
| Dec 31, 2024 | 1.84B | -20.16% |
| Dec 29, 2023 | 2.31B | -11.06% |
| Dec 30, 2022 | 2.60B | 23.47% |
| Dec 31, 2021 | 2.10B | -9.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 413.38M |
| CytoDyn | 304.50M |
| Silence Therapeutics | 213.03M |
| Vaxart | 145.24M |
| HST Global | 139.70M |
| BioStem Technologies | 113.23M |
| Nuo Therapeutics | 80.63M |
| VitaSpring Biomedical | 51.78M |